Alternatives to Charles River Laboratories International, Inc.

A global leader in clinical pharmacology and bioanalytical sciences.

Global CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.

Israel's leading bio-foundry for synthetic biology innovation, spanning ideation to proof-of-concept.

Leveraging AI and advanced analytics to drive innovation in healthcare and life sciences.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing novel male contraceptives.

Global contract research, development, and manufacturing organization for pharmaceutical and biopharmaceutical industries.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered research assistant for scientific literature review and data extraction.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A biotechnology company developing genetic therapies for rare disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

AI company using federated learning to solve biological complexity and accelerate drug discovery.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

AI-powered breast cancer detection and risk assessment solutions.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

H1 is a healthcare data platform that connects life sciences companies with healthcare professionals.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

Developing ultrasound-mediated nonviral genetic medicines.

Developing oral small molecule medicines for immunological and chronic diseases.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).

Developing highly targeted, small molecule medicines.

Advancing next-generation mRNA medicines.

AI-powered antibody discovery platform.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

A global pure-play dermatology company focused on injectable aesthetics, dermatological skincare, and therapeutic medicine.

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

Developing a new class of anti-IgE therapy for multiple atopic conditions.

A biotechnology company focused on developing novel enzyme-based therapies for reflux disease.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Develops, manufactures, and markets radiopharmaceuticals for diagnostic and therapeutic applications.

Provides regulated, secure, and high-yield digital asset solutions for institutional and corporate treasuries.

AI tools for product lifecycle management in medtech and pharma.

Immunotherapy company targeting oncology and autoimmune diseases.

AI platform for engineering molecular glues to create a new class of medicines.

A biotechnology company focused on oncology drug discovery.

Developing first-in-class oral therapy for BK polyomavirus infections.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

Advancing scalable microbiome-based therapeutics for severe and chronic diseases.

Clinical-stage immunotherapy company developing novel treatments for cancer.

Clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.

Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases.

Scalable, one-time curative in-vivo gene editing therapies.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Developing a new histotripsy therapeutic platform for cancer treatment.